Výsledky vyhledávání - "Van den Bergh RCN"

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review

Autor: Heidegger, I., Kesch, C., Kretschmer, A., Tsaur, I., Ceci, F., Valerio, M., Tilki, D., Marra, G., Preisser, F., Fankhauser, C.D., Zattoni, F., Chiu, P., Puche-Sanz, I., Olivier, J., van den Bergh, RCN, Kasivisvanathan, V., Pircher, A., Virgolini, I., Gandaglia, G.

Publikováno v: Therapeutic advances in medical oncology, vol. 14, pp. 17588359221081922

Radioligand therapy with Lutetium-177 (177Lu)-Prostate-specific membrane antigen (PSMA) has shown to prolong survival in metastatic castration resistant prostate cancer (mCRPC). One of the major challenges for clinicians in the future is to select th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1900::5bc0559e3c62b08fa4bd20ff9141d7ee
https://serval.unil.ch/notice/serval:BIB_FEAACAC3A245

Zobrazit plný text záznamu

Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives

Autor: Kretschmer, A., van den Bergh, RCN, Martini, A., Marra, G., Valerio, M., Tsaur, I., Heidegger, I., Kasivisvanathan, V., Kesch, C., Preisser, F., Fankhauser, C.D., Zattoni, F., Ceci, F., Olivier, J., Chiu, P., Puche-Sanz, I., Thibault, C., Gandaglia, G., Tilki, D.

Publikováno v: Cancers, vol. 14, no. 1, pp. 147

With the therapeutic landscape of advanced prostate cancer rapidly evolving and oncological benefits being shown for a plethora of new agents and indications, health-related quality of life (HRQOL)-associated evidence is still subpar. In the current

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1900::fcc814079d433c09125bdc848024eb06
https://serval.unil.ch/notice/serval:BIB_F08AFBD56FCD

Zobrazit plný text záznamu

Radical Prostatectomy: Sequelae in the Course of Time

Autor: Kesch, C., Heidegger, I., Kasivisvanathan, V., Kretschmer, A., Marra, G., Preisser, F., Tilki, D., Tsaur, I., Valerio, M., van den Bergh, RCN, Fankhauser, C.D., Zattoni, F., Gandaglia, G.

Publikováno v: Frontiers in surgery, vol. 8, pp. 684088

Objective: Radical prostatectomy (RP) is a frequent treatment for men suffering from localized prostate cancer (PCa). Whilst offering a high chance for cure, it does not come without a significant impact on health-related quality of life. Herein we r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1900::5ce21202b55f87c31a4a587e8dfb2210
https://serval.unil.ch/resource/serval:BIB_FD54FA7598E0.P001/REF.pdf

Zobrazit plný text záznamu

Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?

Autor: Marra G, Ploussard G, Futterer J, Valerio M, De Visschere PJL, Tsaur I, Tilki D, Ost P, Gandaglia G, Van den Bergh RCN, Surcel C, Kretschmer A, Heidegger I, Borgmann H, Mathieu R

Publikováno v: World Journal of Urology, 37, 2, pp. 277-287
World Journal of Urology, 37, 277-287

Item does not contain fulltext PURPOSE: To review the evidence addressing current controversies around prostate biopsy. Specific questions explored were (1) mpMRI targeted (TgBx) alone versus combined with systematic (SBx) biopsy; (2) cognitive versu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01dbc8c70ff368a8899d8bb2a748d750
https://hdl.handle.net/2066/203310

Zobrazit plný text záznamu

Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey

Autor: Marra, G, Ploussard, G, Ost, P, De Visschere, PJL, Briganti, A, Gandaglia, G, Tilki, D, Surcel, CI, Tsaur, I, Van Den Bergh, RCN, Kretschmer, A, Borgmann, H, Gontero, P, Ahmed, HU, Valerio, M, EAU-YAU Prostate Cancer Working Party

Publikováno v: 529.e22
529.e11

Introduction: The urological community's opinion over focal therapy (FT) for prostate cancer (PCa) has never been assessed. Our aim was to investigate the current opinion on FT in the European urological community. Methods: A 25 -item questionnaire w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61b7d36a990e88e135d3446801d91e3
https://doi.org/10.1016/j.urolonc.2018.08.013

Zobrazit plný text záznamu

Akademický článek

Instructional session: controversies of prostate cancer screening and active surveillance for low risk prostate cancer -- the impact for man and relatives.

Autor: van Muilekom E, van den Bergh RCN, Drudge-Coates L

Publikováno v: European Journal of Oncology Nursing; Apr2010 Supplement 1, Vol. 14, pS9-S9, 1p

Zobrazit plný text záznamu

A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research

Publikováno v: Bates, A S, Ayers, J, Kostakopoulos, N, Lumsden, T, Schoots, I G, Willemse, P-P M, Yuan, Y, van den Bergh, R C N, Grummet, J P, van der Poel, H G, Rouvière, O, Moris, L, Cumberbatch, M G, Lardas, M, Liew, M, van den Broeck, T, Gandaglia, G, Fossati, N, Briers, E, de Santis, M, Fanti, S, Gillessen, S, Oprea-Lager, D E, Ploussard, G, Henry, A M, Tilki, D, van der Kwast, T H, Wiegel, T, N'Dow, J, Mason, M D, Cornford, P, Mottet, N & Lam, T B L 2021, ' A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research ', European Urology Oncology, vol. 4, no. 3, pp. 405-423 . https://doi.org/10.1016/j.euo.2020.12.008

Context The clinical effectiveness of focal therapy (FT) for localised prostate cancer (PCa) remains controversial. Objective To analyse the evidence base for primary FT for localised PCa via a systematic review (SR) to formulate clinical practice re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::770c7a80ee6cf9c6872f7992769e5229
https://research.vumc.nl/en/publications/15a86d3a-aff2-4ff0-ba23-b8566dcc6c90

Zobrazit plný text záznamu

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Publikováno v: Mottet, N, van den Bergh, R C N, Briers, E, van den Broeck, T, Cumberbatch, M G, de Santis, M, Fanti, S, Fossati, N, Gandaglia, G, Gillessen, S, Grivas, N, Grummet, J, Henry, A M, van der Kwast, T H, Lam, T B, Lardas, M, Liew, M, Mason, M D, Moris, L, Oprea-Lager, D E, van der Poel, H G, Rouvière, O, Schoots, I G, Tilki, D, Wiegel, T, Willemse, P-P M & Cornford, P 2021, ' EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent ', European Urology, vol. 79, no. 2, pp. 243-262 . https://doi.org/10.1016/j.eururo.2020.09.042
European Urology, 79(2), 243-262. Elsevier

Objective: To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acbc78382b826c2c7d42855f25bbfe87

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání